Praticima, specialist in equipment dedicated to medication flows within healthcare establishments, announces the acquisition of IMS Medical, based in the Netherlands.
Founded in 2006, IMS Medical is a Dutch company specialising in the design, manufacture and distribution of a mechanised pill crushing solution called “Severo”, which is mainly distributed to hospitals and nursing homes. By improving the safety of the medication delivery chain and allowing healthcare professionals to save time during their daily routine, IMS Medical’s offer is perfectly aligned with the strategy developed by the Praticima Group over the recent years, aimed at further enhancing the medication circuit within healthcare establishments and the everyday work of healthcare staff.
By enabling Praticima to offer a complete range of pill crushing solutions, the acquisition of IMS will allow the Group to become a European leader in this niche market offering excellent growth prospects. This acquisition will further strengthen Praticima’s international commercial positions by leveraging IMS’s distribution network in over 30 countries.
The Praticima Group, which has been acquired by Sparring Capital in April 2022, is now aiming to reach €31m revenues by 2023.
To finance this operation, the Group has been supported by its banking pool (CIC Lyonnaise de Banque, BNP Paribas, Société Générale).
Fabrice Léo, President of Praticima, comments: “As we have been importing the Severo solution manufactured by IMS Medical into France for over 15 years, it seemed appropriate to make this acquisition in order to become the European leader in pills crushing solution market. This acquisition is perfectly in line with our strategy of internationalisation, and will enable us to acquire market share in new countries worldwide.”
Adrien de la Bouillerie, Senior Investment Director at Sparring Capital adds: “This first acquisition is an important step in the creation of a major European player in the medication flow solution, dedicated to the safety of medication delivery and the well-being of healthcare staff. It will enable the Group to extend its PDA (Preparation of Doses to be Administered) product offering and benefit from a distribution network in more than 30 countries.”
Liste des intervenants sur l’opération :
Management
Fabrice Léo, Fabien Mazarico
Sparring Capital
Arnaud Leclercq, Adrien de La Bouillerie, Raphaël Campion
Senior lenders
CIC Lyonnaise de Banque, Société Générale, BNP Paribas
Investor advisors
Legal advisors
Transaction : HVG Law (Joram van den Berg, Tim Groeneweg)
Corporate : Mermoz Avocats (Thomas Hermetet, Virginie Florance, Laëtitia Ayoub)
Legal and social due diligence
HVG Law (Joram van den Berg, Tim Groeneweg)
Financial and tax due diligence
BMA (Thomas Kersaho)
Senior lenders advisors
Legal advisor
De Pardieu (Corentin Coatalem, Aude Fourgassié), Houthoff
Seller advisors
M&A advisor
Erik Twisk
Legal advisor
Sarfaty Advocaten (Remco Verkerke, Léon Graal)